NIH Weekly Funding Opportunities and Policy Notices
Funding Opportunity PA-18-613 from the NIH Guide for Grants and Contracts. The Mentored Career Transition Award for NIMH Intramural Fellows (K22) is a two-phase, mentored career development award program that is intended to facilitate a timely transition of qualified postdoctoral fellows in the NIMH Division of Intramural Programs (DIRP) from intramural postdoctoral research positions to extramural, academic tenure-track or equivalent faculty positions at eligible U.S. institutions. Both the intramural and extramural phases will be mentored, and the award will provide research support during the extramural phase to help awardees launch competitive, independent research programs. This Funding Opportunity Announcement (FOA) is designed specifically for applicants proposing to serve as the lead investigator of an independent clinical trial, a clinical trial feasibility study, or a separate ancillary study to an existing trial, as part of their research and career development. Applicants not planning an independent clinical trial, or proposing to gain research experience in a clinical trial led by another investigator, must apply to companion FOA (PA-18-NNN).
Funding Opportunity PAR-18-605 from the NIH Guide for Grants and Contracts. This Funding Opportunity Announcement (FOA) encourages transdisciplinary research that will leverage cognitive neuroscience to improve traditional measurement of cognitive impairment following cancer treatment, often referred to as chemobrain. A better understanding of the acute- and late-term cognitive changes following exposure to adjuvant chemotherapy and molecularly-targeted treatments, including hormonal therapy, for non-central nervous system tumors can inform clinical assessment protocols with downstream implications for survivorship care plans.
Funding Opportunity PAR-18-606 from the NIH Guide for Grants and Contracts. This Funding Opportunity Announcement (FOA) encourages transdisciplinary research that will leverage cognitive neuroscience to improve traditional measurement of cognitive impairment following cancer treatment, often referred to as chemobrain. A better understanding of the acute- and late-term cognitive changes following exposure to adjuvant chemotherapy and molecularly-targeted treatments, including hormonal therapy, for non-central nervous system tumors can inform clinical assessment protocols with downstream implications for survivorship care plans.
Notice NOT-HL-18-589 from the NIH Guide for Grants and Contracts
Notice NOT-TR-18-017 from the NIH Guide for Grants and Contracts
Notice NOT-AA-18-003 from the NIH Guide for Grants and Contracts
Funding Opportunity RFA-HL-19-001 from the NIH Guide for Grants and Contracts. This Funding Opportunity Announcement (FOA) solicits one five-year grant application from institutions/organizations to serve as the Coordination Center (CC) for the Programs to Increase Diversity Among Individuals Engaged in Health-Related Research (PRIDE) Summer Institute programs This FOA runs parallel with a separate FOA that solicits applications for the PRIDE Summer Institutes(See RFA-HL-17-NNN). PRIDE Summer Institute (SI) programs are designed to provide research education experiences that enable junior faculty and postdoctoral scientists transitioning into academia, and from backgrounds underrepresented in the biomedical sciences, to further develop their research skills and knowledge to become competitive NIH grants applicants and scientists. The purpose of the CC is primarily to support and complement the activities of the Summer Institutes as follows: * Facilitate outreach, participant recruitment, candidate selection, and program-wide organization * Support and assist with the identification and orientation of SI program mentors * Support matriculants research education experiences through webinar and in person learning activities * Administrate and facilitate equitable distributions of research related resources and activities * Facilitate coordination of research education and evaluation activities between the SI awardees, enrolled participants and the NHLBI * Develop orientation and support other skill development activities for mentors * Support mentoring of program participants by assisting the SIs with the formation of participants' mentorship committees; * Conduct cross-site and cross-program evaluations, including use of data from previous PRIDE cohorts to document program accomplishments, trends and trajectories. In addition, the CC will also plan, arrange, support, and facilitate the Annual PRIDE Program-wide Meetings, the monthly Steering Committee meetings, and other PD/PI meetings for the program overall. To be competitive for review, all C
Funding Opportunity RFA-HL-19-002 from the NIH Guide for Grants and Contracts. The NIH Research Education Program (R25) supports research education activities in the mission areas of the NIH. The over-arching goal of this National Heart, Lung, and Blood Institute R25 program is to support educational activities that complement and/or enhance the training of junior faculty from backgrounds underrepresented in the biomedical sciences so as to meet the nations biomedical, behavioral and clinical research needs and enhance the diversity of its workforce. The major intent of this Research Education Program (R25) is to establish long-term mentoring that will enable participants to develop a research program and obtain NIH funding.This FOA specifically invites applications from senior faculty, established researchers, and experienced mentors to develop and direct the SIs of the PRIDE program in order to mentor promising candidates with scientific focus in heart, lung, blood and sleep (HLBS) disorders research areas. To accomplish the stated over-arching goal, this FOA will support creative educational activities with a primary focus on Research Experiences, Mentoring Activities and Courses for Skills Development in Heart, Lung, Blood, Sleep disorders research and cross-cutting methodological approaches relevant to these scientific areas.
Notice NOT-NR-18-001 from the NIH Guide for Grants and Contracts
Funding Opportunity PA-18-607 from the NIH Guide for Grants and Contracts. This Funding Opportunity Announcement (FOA) encourages Small Business Innovation Research SBIR grant applications from small business concerns (SBCs) to address highly innovative methods and technologies that significantly advance the field of natural products.
Funding Opportunity PAR-18-608 from the NIH Guide for Grants and Contracts. This Funding Opportunity Announcement (FOA) encourages Small Business Technology Transfer (STTR) grant applications from small business concerns (SBCs) to address highly innovative methods and technologies that significantly advance the field of natural products.
Funding Opportunity PAR-18-598 from the NIH Guide for Grants and Contracts. The High-End Instrumentation (HEI) Grant Program encourages applications from groups of NIH-supported investigators to purchase or upgrade a single item of expensive, specialized, commercially available instruments or integrated systems that cost at least $600,001. The maximum award is $2,000,000. Types of instruments supported include, but are not limited to: X-ray diffraction systems, nuclear magnetic resonance (NMR) and mass spectrometers, DNA and protein sequencers, biosensors, electron and confocal microscopes, cell-sorters, and biomedical imagers.
Funding Opportunity PAR-18-600 from the NIH Guide for Grants and Contracts. The Shared Instrument Grant (SIG) Program encourages applications from groups of NIH-supported investigators to purchase or upgrade a single item of expensive, specialized, commercially available instruments or integrated systems. The minimum award is $50,000. There is no maximum price requirement; however, the maximum award is $600,000. Types of instruments supported include, but are not limited to: X-ray diffractometers, mass and nuclear magnetic resonance (NMR) spectrometers, DNA and protein sequencers, biosensors, electron and light microscopes, cell sorters, and biomedical imagers.
Funding Opportunity PAR-18-604 from the NIH Guide for Grants and Contracts. The purpose of this Funding Opportunity Announcement (FOA) is to support enhanced human and animal food safety by strengthening the capacity, collaboration, and integration of food-safety laboratories and networks, thereby facilitating an effective and coordinated response to future human and animal food safety issues. The current FOA solicits applications from FDA's Veterinary Laboratory Investigation and Response Network laboratories for research related to emerging public food safety issues identified by the Vet-LIRN network office (VPO), for equipment and personnel necessary to expand laboratory capability and capacity, and for other related activities. This cooperative agreement program is intended to build domestic laboratory capacity as put forth in the Food Safety Modernization Act (FSMA), by developing the Vet-LIRN laboratory Network capabilities and capacity to investigate potential animal foodborne illness outbreaks.
Funding Opportunity PAR-18-596 from the NIH Guide for Grants and Contracts. The purpose of this Funding Opportunity Announcement (FOA) is to invite applications proposing research on current topics in Alzheimer's disease. Further information on the specific topics of interest will be announced through a series of notices published in late January and early February of 2018.
Funding Opportunity PAR-18-597 from the NIH Guide for Grants and Contracts. This Funding Opportunity Announcement (FOA) is to encourage Research Project Grant (R01) applications to pursue clinical observational (CO) studies to obtain data necessary for designing clinical studies for musculoskeletal, rheumatic, or skin diseases or conditions. A future clinical study may include a clinical trial or observational study. Research data from observational cohort studies can enhance clinical study design by providing essential information about disease symptoms, stages and timing of disease progression, comorbid conditions, availability of potential research participants, and outcomes that are important to patients. CO studies also can facilitate efforts to develop and/or validate objective biomarkers or subjective outcome measures for use in future clinical studies. Applicants to this FOA are encouraged to propose studies that address significant obstacles or questions in the design of a clinical project, such as determining the appropriate primary or secondary outcome measures, or identifying the stages of disease during which patients are most likely to respond to an intervention. Only observational studies will be supported through this FOA.
Funding Opportunity PA-18-602 from the NIH Guide for Grants and Contracts. The purpose of this FOA is two-fold: (1) to advance identification of male-females differences in drug and alcohol research outcomes, to uncover the mechanisms of those differences, and to conduct translational research on those differences, and (2) to advance research specific to women or highly relevant to women. Both preclinical and clinical studies are sought across all areas of drug and alcohol research
Funding Opportunity PA-18-601 from the NIH Guide for Grants and Contracts. The purpose of this FOA is two-fold: (1) to advance identification of male-females differences in drug and alcohol research outcomes, to uncover the mechanisms of those differences, and to conduct translational research on those differences, and (2) to advance research specific to women or highly relevant to women. Both preclinical and clinical studies are sought across all areas of drug and alcohol research
Funding Opportunity PA-18-603 from the NIH Guide for Grants and Contracts. The purpose of this FOA is two-fold: (1) to advance identification of male-females differences in drug and alcohol research outcomes, to uncover the mechanisms of those differences, and to conduct translational research on those differences, and (2) to advance research specific to women or highly relevant to women. Both preclinical and clinical studies are sought across all areas of drug and alcohol research
Notice NOT-HD-17-033 from the NIH Guide for Grants and Contracts